Xinyuan Ed Wu

Xinyuan Ed Wu has over 18 years of experience in the pharmaceutical and biosciences industry. Xinyuan Ed is currently the Senior Director of Chemistry at Tango Therapeutics, a position they have held since February 2023. Prior to this, they were the Director of Chemistry at Tango Therapeutics from March 2021 to January 2023. Before joining Tango Therapeutics, Xinyuan worked at Astellas Pharma US as an Associate Director from August 2018 to March 2021. Xinyuan Ed started their career at Hydra Biosciences in December 2007, where they held various roles including Associate Director of Chemistry, Manager of Chemistry, Senior Scientist, and Scientist II, until January 2018. Xinyuan also gained experience as a Senior Scientist/Research Scientist at Alantos Pharmaceuticals (Amgen) from December 2003 to November 2007.

Xinyuan Ed Wu attended Stony Brook University from 1998 to 2003, and during this time, they did not obtain a degree or specify a field of study. Prior to that, they studied Chemistry at the University of Wisconsin-Milwaukee from 1997 to 1998. Xinyuan Ed Wu earned their Bachelor of Science degree in Chemistry from Peking University, where they studied from 1992 to 1997. There is no information available regarding their education at rdfz.